[pending] MOTRIN 2'S DISP.- 50CT
Pending LLM rewrite. Source: FDA_DRUG D-0271-2026.
- Product
- MOTRIN 2'S DISP.- 50CT
- Category
- Drug
- Distribution
- Distributed nationwide
Category
FDA recalls of prescription and over-the-counter drugs.
FDA drug recalls cover prescription medicines, over-the-counter products, biologic and gene therapies, and active pharmaceutical ingredients (the raw drug substances that manufacturers compound into finished products). Recall classifications follow the same Class I / II / III system as food, and most published recalls are Class II — the product is unlikely to cause permanent harm but doesn't meet specification.
The most common reasons for a drug recall are out-of-specification potency or dissolution (the active ingredient is present in too high or too low a dose), microbial contamination, particulate matter in injectables, mix-ups during packaging where bottles end up with the wrong tablets, and nitrosamine impurities in certain drug classes. Many drug recalls are at the lot level — the manufacturer's whole product line is still safe to use, but specific production lots are pulled.
If a recall affects your medication: don't stop taking it on your own. Call your prescriber or pharmacist before doing anything. Stopping a prescribed drug abruptly can be more dangerous than the issue prompting the recall. Most drug-recall remedies route through the dispensing pharmacy, who'll either swap your supply for an unaffected lot or coordinate a refund with the manufacturer.
Pending LLM rewrite. Source: FDA_DRUG D-0271-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0269-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0262-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0270-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0268-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0261-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0257-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0260-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0254-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0253-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0292-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0248-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0289-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0288-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0251-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0252-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0250-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0255-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0249-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0243-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0246-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0247-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0245-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0244-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0241-2026.
Looking for a different category? Browse all recalls.